NM
FTH

Newtyn Management’s Faeth Therapeutics FTH Stock Holding History

Newtyn Management’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-46,512
Closed -$977K – 45
2024
Q1 		$977K Sell
46,512
-32,089
-41% -$553K 0.19% 37
2023
Q4 		$1.09M Sell
78,601
-11,399
-13% -$156K 0.21% 37
2023
Q3 		$1.35M Sell
90,000
-1,362
-1% -$29.3K 0.33% 35
2023
Q2 		$2.08M Buy
91,362
+14,316
+19% +$419K 0.49% 30
2023
Q1 		$2.31M Buy
77,046
+19,268
+33% +$571K 0.45% 45
2022
Q4 		$1.72M Buy
57,778
+37,028
+178% +$1.09M 0.36% 39
2022
Q3 		$643K Hold
20,750
– – 0.14% 62
2022
Q2 		$942K Buy
+20,750
New +$778K 0.18% 63

Other funds holding FTH

IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return